David A Bernal-Estevez
Overview
Explore the profile of David A Bernal-Estevez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez I, Bernal-Estevez D, Llano-Leon M, Bonilla C, Parra-Lopez C
PLoS One
. 2023 Feb;
18(2):e0280851.
PMID: 36763585
Breast cancer is the leading cause of cancer deaths in women worldwide. It has been observed that the incidence of breast cancer increases linearly with age after 45, which suggest...
2.
Bernal-Estevez D, Ortiz Barbosa M, Ortiz-Montero P, Cifuentes C, Sanchez R, Parra-Lopez C
Front Immunol
. 2021 Sep;
12:669965.
PMID: 34489928
Introduction: Animal studies and preclinical studies in cancer patients suggest that the induction of immunogenic cell death (ICD) by neoadjuvant chemotherapy with doxorubicin and cyclophosphamide (NAC-AC) recovers the functional performance...
3.
Chamucero-Millares J, Bernal-Estevez D, Parra-Lopez C
Cell Immunol
. 2021 Jan;
360:104257.
PMID: 33387685
Clonal anergy and depletion of antigen-specific CD8+ T cells are characteristics of immunosuppressed patients such as cancer and post-transplant patients. This has promoted translational research on the adoptive transfer of...
4.
Bernal-Estevez D, Garcia O, Sanchez R, Parra-Lopez C
BMC Cancer
. 2018 Jan;
18(1):77.
PMID: 29334915
Background: Vaccination of mice with tumors treated with Doxorubicin promotes a T cell immunity that relies on dendritic cell (DC) activation and is responsible for tumor control in vaccinated animals....